1. Durbin, Adam D, Wang, Tingjian, Wimalasena, Virangika K, Look, A Thomas, Qi, Jun. . EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. In Cancer discovery, 12, 730-751. doi:10.1158/2159-8290.CD-21-0385. https://pubmed.ncbi.nlm.nih.gov/34772733/
2. Huang, Xiaoyu, Rui, Xue, Zhang, Shuang, Rong, Weining, Sheng, Xunlun. 2023. De novo variation in EP300 gene cause Rubinstein-Taybi syndrome 2 in a Chinese family with severe early-onset high myopia. In BMC medical genomics, 16, 84. doi:10.1186/s12920-023-01516-9. https://pubmed.ncbi.nlm.nih.gov/37085840/
3. Van Gils, Julien, Magdinier, Frederique, Fergelot, Patricia, Lacombe, Didier. 2021. Rubinstein-Taybi Syndrome: A Model of Epigenetic Disorder. In Genes, 12, . doi:10.3390/genes12070968. https://pubmed.ncbi.nlm.nih.gov/34202860/
4. Zhang, Jinghui, Ding, Li, Holmfeldt, Linda, Downing, James R, Mullighan, Charles G. 2012. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. In Nature, 481, 157-63. doi:10.1038/nature10725. https://pubmed.ncbi.nlm.nih.gov/22237106/
5. Martínez-Pinteño, Albert, Gassó, Patricia, Prohens, Llucia, Mas, Sergi, Rodríguez, Natalia. 2021. Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data. In Frontiers in pharmacology, 12, 729474. doi:10.3389/fphar.2021.729474. https://pubmed.ncbi.nlm.nih.gov/34483940/
6. Yaguchi, Akinori, Ishibashi, Takeshi, Terada, Kazuki, Manabe, Atsushi, Kiyokawa, Nobutaka. 2017. EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells. In International journal of hematology, 106, 269-281. doi:10.1007/s12185-017-2220-6. https://pubmed.ncbi.nlm.nih.gov/28378055/
7. Furlan, Tobias, Kirchmair, Alexander, Sampson, Natalie, Handle, Florian, Culig, Zoran. 2021. MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors. In The American journal of pathology, 191, 1094-1107. doi:10.1016/j.ajpath.2021.02.017. https://pubmed.ncbi.nlm.nih.gov/33705753/
智鼠故事 
